pharmaphorum

AUGUST 7, 2020

Health technology firms Cerner and LRVHealth have invested $6 million in Xealth to scale up its business offering digital health tools to patients and clinicians. Xealth and Cerner hope to make it easier and more convenient for patients and clinicians to accelerate health care in a more consumer-centric experience.”.

Cerner 59

Cerner 59

Pharmaceutical Technology

APRIL 11, 2023

Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies. Together, Cerner Enviza and John Snow Labs have all the right expertise, data and technology to make it happen.”

Cerner 59

Cerner Hospitals 59

pharmaphorum

NOVEMBER 9, 2021

Join this Cerner Enviza webinar, held in partnership with pharmaphorum, for a 45-minute, evidence-backed discussion on the paradoxical question that is “How do I succeed in oncology?”. Michael Gaschler, PhD , Senior Consultant, Oncology, Cerner Enviza. Jeanette Hodgson, Global Head of Qualitative Strategy, Cerner Enviza.

Cerner 98

Cerner 98

pharmaphorum

DECEMBER 20, 2021

In a year already marked by big-ticket deals in the digital health arena, there may be even more to come, as reports circulate of a $30 billion offer looming for electronic health record (EHR) specialist Cerner by Oracle. The post Is Oracle about to buy electronic health record provider Cerner? billion this year. .”

Cerner 52

Cerner Medical Records 52

PharmExec

OCTOBER 17, 2022

Combining Cerner Enviza’s real-world datasets containing de-identified, person-centric, longitudinal records offers a vast resource for expanding the potential of safety signaling.

Cerner 52

Cerner 52

pharmaphorum

NOVEMBER 17, 2021

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the speakers discuss qualitative real-world evidence and a unique dementia project from Singapore. Jeanette Hodgson , global head of qualitative strategy at, Cerner Enviza. Yew Ying Jie , senior analyst, Cerner Enviza.

Cerner 52

Cerner 52

pharmaphorum

NOVEMBER 17, 2021

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the speakers discuss qualitative real-world evidence and a unique dementia project from Singapore. Jeanette Hodgson , global head of qualitative strategy at, Cerner Enviza. Yew Ying Jie , senior analyst, Cerner Enviza.

Cerner 52

Cerner 52

pharmaphorum

AUGUST 3, 2022

The key, according to Ryan Mogg, senior director of real-world data and clinical research at Cerner; Michael Ibara, chief data officer at Elligo; and Andy Stankus, general manager of real-world evidence at Kantar Health, was collecting and connecting the right data, and supporting sites to get involved.

Cerner 124

Cerner 124

Outsourcing Pharma

DECEMBER 15, 2020

The two firms will work together to broaden the technology, tools, and resources available to hospitals and practices in less-accessible communities.

Cerner 52

Cerner Hospitals 52

Outsourcing Pharma

NOVEMBER 4, 2021

This monthâs announcements of programs, names, appointments, hires, and other happenings includes items from Emmes, Science 37, Cerner and other companies.

Cerner 52

Cerner 52

pharmaphorum

JANUARY 24, 2022

Last month, arch-rival Oracle announced a $28 billion takeover of electronic health record company Cerner , while 2021 also saw Microsoft’s $19.7 IBM’s step back from health comes as tech rivals are still piling into the sector.

Cerner 111

Cerner 111

Outsourcing Pharma

FEBRUARY 2, 2021

Thanks to collaborations with Cerner, amassing of proprietary data and other achievements, the trial solutions firm has hit a significant access milestone.

Cerner 40

Cerner 40

pharmaphorum

JULY 12, 2022

There are some warning signals in the numbers, including most notably an absence of digital health companies going public – zero in the first six months of the year, coming after 23 over the course of 2021 – while a few formerly public firms, including Castlight Health, SOC Telemed, and Cerner went back into private hands.

Cerner 83

Cerner 83

pharmaphorum

JANUARY 19, 2022

Once widely acknowledged as so special that only scientists and clinical specialists need apply, oncology has become exponentially more clinically targeted and sophisticated over the last decade. Yet how many other therapy areas have market leaders that don’t even have clinical approval in that indication?

Cerner 52

Cerner 52